Back to blog
Access & Policy
March 10, 2026

Naloxone Access in Ohio: A ZIP Code Guide

Ohio's statewide standing order means any pharmacy can dispense Narcan without a prescription. But access is uneven. We mapped where the gaps are.

Ohio has operated a statewide standing order for naloxone since 2015, meaning any licensed Ohio pharmacist can dispense naloxone — under any of its brand names (Narcan, Kloxxado, Revive) or as a generic — without a personal prescription from a physician. In theory, this makes naloxone universally accessible to any Ohioan who walks into a pharmacy. In practice, access is uneven in ways that directly correlate with overdose mortality rates.

Where the Gaps Are

The gaps are geographic, economic, and structural. Rural pharmacies frequently don't stock naloxone or require special ordering. In lower-income urban neighborhoods, some pharmacies do stock it but chain pharmacy staff are inconsistently trained on the standing order, leading to unnecessary refusals. The nasal spray formulation (Narcan) is the most commonly stocked option and requires no training to use, but its retail price of $20–$50 for a two-dose kit remains a barrier for people with no insurance and no cash.

Community-based distribution programs fill many of the gaps that pharmacies miss. Harm reduction organizations, some county health departments, and certified peer recovery supporters can distribute naloxone under Project DAWN (Deaths Avoided With Naloxone), Ohio's statewide overdose education and naloxone distribution program. Live Now Recovery maps Narcan distribution sites alongside MAT providers so people can find both resources in a single search, reducing the time between need and access.

Why Carrying Naloxone Saves Lives

Carrying naloxone does not enable drug use — it enables survival. Every person in recovery, every family member, every peer specialist, and every first responder who carries naloxone is extending the window of time in which someone can get help. The research is unambiguous: community-level naloxone distribution reduces overdose mortality without increasing drug use. Closing the distribution gap in Ohio's Region 13 is one of the fastest, cheapest interventions available to policymakers today.

We use essential cookies to keep this platform working. We never track patients or collect health data. Privacy Policy

Manage Cookies